24/7 Market News – (NASDAQ:RGLS) REGULUS THERAPEUTICS INC. Just announced the FDA orphan drug designation from the FDA.

24/7 Market News – (NASDAQ:RGLS) REGULUS THERAPEUTICS INC. Just announced the FDA orphan drug designation from the FDA.

REGULUS THERAPEUTICS INC

Shares are up slightly in pre-market on light trading. currently .30 on only 498 trades.

Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease

https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-receipt-of-fda-orphan-drug-designation-for-rgls8429-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd-301571856.html

Signup today for free and be the first to get notified of breaking news.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist